Ketoacidosis Class Action Lawsuit

A growing number of lawsuits accuse drug-makers of failing to warn about ketoacidosis, a severe side effect in which the blood is too acidic. The FDA has received dozens of reports of patients who were hospitalized with ketoacidosis after taking a diabetes medications like Invokana.

What You Can Do & How We Can Help

The Schmidt Firm, PLLC is currently accepting diabetes medication induced injury cases in all 50 states. If you or somebody you know has been diagnosed with diabetic acidosis, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Judges May Centralize Individual Lawsuits

Janssen Pharmaceuticals has been hit with several lawsuits from people who developed ketoacidosis after taking Invokana. These lawsuits are not part of a class action — they are individual lawsuits. As the litigation continues to grow, judges may decide to centralize the cases in a “mass-tort” or Multi-District Litigation (MDL).

Overview

People with type-2 diabetes who use medications in the SLGT2 (sodium-glucose cotransporter-2) inhibitor class can develop ketoacidosis, according to recent warnings from the FDA. The agency received 73 reports of this side effect from March 2013 through May 2015. All of the patients were hospitalized. In December 2015, the FDA ordered drug-makers to add stronger warnings.

Diabetes Drugs in the SGLT2 Inhibitor Class

What is Ketoacidosis?

Diabetic Ketoacidosis (DKA) is a medical emergency in which the blood becomes too acidic. It occurs when body can’t use glucose (sugar) from food as an energy source because the pancreas is not making enough insulin. Instead, the body starts burning fat. This releases fatty-acids into the bloodstream, which the liver converts into toxins called ketones. As ketones levels increase, blood pH becomes more acidic and ketoacidosis occurs.

Complications

Dehydration
Low blood pressure
Shock
Cerebral edema (swelling in the brain)
Heart rhythm abnormalities
Diabetic coma (unconsciousness)
Death

What is the problem?

The Schmidt Firm, PLLC is nationally recognized as a class action law firm. However, our attorneys are not currently filing a ketoacidosis class action. Instead, we are filing individual lawsuits against pharmaceutical companies who sold diabetes medications in the SGLT2 inhibitor class on behalf of people who were diagnosed with ketoacidosis.

About Class Actions

Class actions are an efficient way to resolve a lot of similar legal claims all at once. Everyone joins together and collectively seeks compensation. Members also share any compensation awarded in a lawsuit verdict or settlement.

Why Our Law Firm is Filing Individual Lawsuits as Opposed to a Class Action

The problem with class actions is that they are not designed to maximize compensation for individual plaintiffs with severe injuries. Another problem is that members may have to accept a “low-ball” settlement or attorneys’ fees that take a huge cut of the payout.

Our lawyers file individual lawsuits because so we can focus on helping people with the most serious injuries. We specialize in helping victims of defective drugs file lawsuits against pharmaceutical companies and seek compensation for their medical expenses, pain and suffering, lost income, and more.

Do I have a Ketoacidosis Lawsuit?

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.